Stem Cell Therapy for Type 1 Diabetes
Diabetes (Type 1)
Under DevelopmentActive
Key Facts
About GIOSTAR
GIOSTAR is a private, clinical-stage biotechnology company focused on translating stem cell science into therapeutic treatments. The company leverages a network of scientific advisors with ties to prestigious US research institutions and operates a major stem cell hospital in India through a government partnership. Its pipeline is broad and pre-commercial, targeting over 30 conditions from blood diseases to neurological disorders, though it appears to be in early clinical or development stages for most programs. The company's model combines therapeutic development with direct patient treatment services at its international centers.
View full company profileTherapeutic Areas
Other Diabetes (Type 1) Drugs
| Drug | Company | Phase |
|---|---|---|
| Monitored Cell Transplant for Diabetes | Minutia | Pre-clinical |